小白云官网网址-outline
East Rutherford, NJ – July 1, 2024 – Cambrex, the leading small molecule company providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it is investing $3.6 million at its Karlskoga, Sweden facility to increase flexible drug substance manufacturing capacity. The work, which will convert a previously customer-dedicated manufacturing train, […]
Learn more